Bain Capital teams with Pfizer to create new neuroscience-focused company

Österreich Nachrichten Nachrichten

Pfizer announced in January it planned to shut down early- and mid-stage neuroscience drug development. But now Pfizer and investment firm Bain Capital are creating a new company. Its name: Cerevel Therapeutics.